Jagsonpal Pharmaceuticals Limited — Board Meeting, 03-11-2025: Outcome of Board Meeting

Jagsonpal Pharmaceuticals' board has announced a meeting where it approved the financial results for the quarter and half-year ended September 30, 2025. Revenue hit ₹150.08 Cr for the half-year, with net profit at ₹23.37 Cr. The company also allotted 104,774 shares under its ESOP.